ATP Synthase Inhibition of Mycobacterium avium Is Not Bactericidal
Open accessThe DOI matches its Crossref record; 16 of the 16 references it cites were found in a registry or an index.
Abstract
The efficacy of ATP synthase inhibitor TMC207 was assessed in early and late Mycobacterium avium infections in mice. In contrast to what was earlier observed for M. tuberculosis , a bacteriostatic effect was obtained. In vitro, the minimal bactericidal concentration (MBC)/MIC ratio was very high. The MBC was more relevant for assessment of pharmacokinetic/pharmacodynamic relationships than the MIC.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“TMC207 is bactericidal towards most species of mycobacteria (109), but is only bacteriostatic against M. avium (118) and M. smegmatis (Berney and Cook, unpublished data).”
From Energetics of Respiration and Oxidative Phosphorylation in Mycobacteria (2014) · cites this paper as [118]
Citations
Cites
A Diarylquinoline Drug Active on the ATP Synthase of Mycobacterium tuberculosis
Andries, K., Verhasselt, P., Guillemont, J., Göhlmann, H. W. H., Neefs, J.-M., Winkler, H., Van Gestel, J., Timmerman, P., Zhu, M., Lee, E., et al. (2005) · Science · doi:10.1126/science.1106753 · Cited by 2,191 · cited 2×
“060 g/ml (1), the weak in vivo activity of TMC207 against M.”
BackgroundResultSelf-citationThe Diarylquinoline TMC207 for Multidrug-Resistant Tuberculosis
Diacon, A. H., Pym, A., Grobusch, M., Patientia, R., Rustomjee, R., Page-Shipp, L., Pistorius, C., Krause, R., Bogoshi, M., Churchyard, G., et al. (2009) · New England Journal of Medicine · doi:10.1056/nejmoa0808427 · Cited by 835
Self-citationMouton, J. W., Dudley, M. N., Cars, O., Derendorf, H., & Drusano, G. L. (2005) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dki079 · Cited by 549
Pulmonary Mycobacterial Infections due to Mycobacterium intracellulare-avium Complex
Rosenzweig, D. Y. (1979) · Chest · doi:10.1378/chest.75.2.115 · Cited by 200
Huang, J. H., Kao, P. N., Adi, V., & Ruoss, S. J. (1999) · Chest · doi:10.1378/chest.115.4.1033 · Cited by 195
In Vitro Antimycobacterial Spectrum of a Diarylquinoline ATP Synthase Inhibitor
Huitric, E., Verhasselt, P., Andries, K., & Hoffner, S. E. (2007) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00181-07 · Cited by 172
Self-citationIn vitro and in vivo activities of clarithromycin against Mycobacterium avium
Fernandes, P. B., Hardy, D. J., McDaniel, D., Hanson, C. W., & Swanson, R. N. (1989) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.33.9.1531 · Cited by 158
Lounis, N., Véziris, N., Chauffour, A., Truffot-Pernot, C., Andries, K., & Jarlier, V. (2006) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00766-06 · Cited by 143
Self-citationBenson, C. A., Williams, P. L., Currier, J. S., Holland, F., Mahon, L. F., MacGregor, R. R., Inderlied, C. B., Flexner, C. W., Neidig, J. L., Chaisson, R. E., et al. (2003) · Clinical Infectious Diseases · doi:10.1086/378807 · Cited by 142
Ethambutol Ocular Toxicity in Treatment Regimens for Mycobacterium avium Complex Lung Disease
Griffith, D. E., Brown‐Elliott, B. A., Shepherd, S., McLarty, J. W., Griffith, L., & Wallace, R. J. (2005) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200407-863oc · Cited by 126
Cited by
NTM drug discovery: status, gaps and the way forward
Wu, M.-L., Aziz, D. B., Dartois, V., & Dick, T. (2018) · Drug Discovery Today · doi:10.1016/j.drudis.2018.04.001 · Cited by 276
Philley, J. V., Wallace, R. J., Benwill, J. L., Taskar, V., Brown-Elliott, B. A., Thakkar, F., Aksamit, T. R., & Griffith, D. E. (2015) · Chest · doi:10.1378/chest.14-2764 · Cited by 225
Energetics of Respiration and Oxidative Phosphorylation in Mycobacteria
Cook, G. M., Hards, K., Vilchèze, C., Hartman, T., & Berney, M. (2014) · Microbiology Spectrum · doi:10.1128/microbiolspec.mgm2-0015-2013 · Cited by 212
“TMC207 is bactericidal toward most species of mycobacteria (109) but is only bacteriostatic against M. avium (118) and M. smegmatis (M. Berney and G. M. Cook, unpublished data).”
BackgroundTmc207: the First Compound of A New class of Potent Anti-Tuberculosis Drugs
Matteelli, A., Carvalho, A. C., Dooley, K. E., & Kritski, A. (2010) · Future Microbiology · doi:10.2217/fmb.10.50 · Cited by 204
Mycobacterium avium Complex Disease
Daley, C. L. (2017) · Microbiology Spectrum · doi:10.1128/microbiolspec.tnmi7-0045-2017 · Cited by 150
Metadata
- Authors
- Lounis, N., Gevers, T., Van Den Berg, J., Vranckx, L., & Andries, K.
- Affiliations
- Johnson & Johnson (United States) (US)
- Department of Antimicrobial Research, Tibotec BVBA, Johnson & Johnson, Turnhoutseweg 30, 2340 Beerse, Belgium
- Corresponding author
- Andries, Koen
- Venue
- Antimicrobial Agents and Chemotherapy
- Publisher
- American Society for Microbiology
- Published
- 2009-11
- Volume
- 53
- Issue
- 11
- Pages
- 4927-4929
- ISSN
- 0066-4804 (ISSN-L)
- 1098-6596
- PMC
- PMC2772307
- OpenAlex
- W2151030507
- Cited by
- 54
- References
- 16
- Citations by year
- 2025: 1 · 2024: 3 · 2023: 2 · 2021: 5 · 2020: 1 · 2019: 7 · 2018: 4 · 2017: 7 · 2016: 3 · 2015: 8 · 2014: 5 · 2013: 4 · 2012: 1
- FWCI
- 0.90
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Licence
- journals.asm.org/non-commercial-tdm-license (tdm)
- Locations
- Antimicrobial Agents and Chemotherapy (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Epidemiology › Mycobacterium research and diagnosis
- Health Sciences › Medicine › Infectious Diseases › Tuberculosis Research and Epidemiology
- Health Sciences › Medicine › Infectious Diseases › Infectious Diseases and Tuberculosis
- Keywords
- ATP synthase inhibitors, bedaquiline, Mycobacterium avium, bacteriostatic activity, minimum bactericidal concentration, minimum inhibitory concentration, pharmacokinetic-pharmacodynamic relationship, nontuberculous mycobacterial infection
- MeSH terms
- Animals, Antitubercular Agents, Enzyme Inhibitors, Female, Mice, Inbred C57BL, Microbial Sensitivity Tests, Mycobacterium avium, Quinolines, Mice, Diarylquinolines
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: ATP Synthase Inhibition of Mycobacterium avium Is Not Bactericidal. https://app.cochat.ai/papers/10.1128/aac.00689-09
- The paper
- Lounis, N., Gevers, T., Van Den Berg, J., Vranckx, L., & Andries, K. (2009). ATP Synthase Inhibition of Mycobacterium avium Is Not Bactericidal. Antimicrobial Agents and Chemotherapy. https://doi.org/10.1128/aac.00689-09
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.